Enhanced tonic GABA A inhibition in typical absence epilepsy

Nature Medicine

Volumn 15, Issue 12, 2009, Pages 1392-1398

  Cope, David W ^a   Di Giovanni, Giuseppe ^a,b   Fyson, Sarah J ^a   Orbán, Gergely ^a,c   Errington, Adam C ^a   Lrincz, Magor L ^a   Gould, Timothy M ^a   Carter, David A ^a   Crunelli, Vincenzo ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MALTA   (Malta)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID CARRIER; GABA TRANSPORTER GAT 1; UNCLASSIFIED DRUG; SLC6A1 PROTEIN, RAT;

ABSENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROGRAPHY; EPILEPTOGENESIS; FEMALE; GABAERGIC SYSTEM; GENERALIZED EPILEPSY; IDIOPATHIC DISEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; THALAMOCORTICAL TRACT; ANIMAL; DRUG ANTAGONISM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

RATTUS;

ANIMALS; EPILEPSY, ABSENCE; GABA PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RECEPTORS, GABA-A;

EID: 71549172835     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2058     Document Type: Article

References (48)

1. Commission on Classifcation and Terminology of the International League Against Epilepsy. Proposal for revised classifcation of epilepsies and epileptic syndromes. Epilepsia 30, 389-399 (1989).
2. Crunelli, V. & Leresche, N. Childhood absence epilepsy: genes, channels, neurons and networks. Nat. Rev. Neurosci. 3, 371-382 (2002).
3. McCormick, D.A. & Contreras, D. On the cellular and network bases of epileptic seizures. Annu. Rev. Physiol. 63, 815-846 (2001).
4. Blumenfeld, H. Cellular and network mechanisms of spike-wave seizures. Epilepsia 46 Suppl 9, 21-33 (2005).
5. von Krosigk, M., Bal, T. & McCormick, D.A. Cellular mechanisms of a synchronized oscillation in the thalamus. Science 261, 361-364 (1993) (Pubitemid 23982772).
6. Huntsman, M.M., Porcello, D.M., Homanics, G.E., DeLorey, T.M. & Huguenard, J.R. Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 283, 541-543 (1999).
7. Wallace, R.H. et al. Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizures. Nat. Genet. 28, 49-52 (2001).
8. Kananura, C. et al. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch. Neurol. 59, 1137-1141 (2002).
9. Maljevic, S. et al. A mutation in the GABAA receptor α1-subunit is associated with absence epilepsy. Ann. Neurol. 59, 983-987 (2006).
10. Macdonald, R.L., Gallagher, M.J., Feng, H.-J. & Kang, J. GABAA receptor epilepsy mutations. Biochem. Pharmacol. 68, 1497-1506 (2004).
11. Caddick, S.J. et al. Excitatory but not inhibitory synaptic transmission is reduced in lethargic (Cacnb4lh) and tottering (Cacna1atg) mouse thalami. J. Neurophysiol. 81, 2066-2074 (1999).
12. Bessaïh, T. et al. Nucleus-specifc abnormalities of GABAergic synaptic transmission in a genetic model of absence seizures. J. Neurophysiol. 96, 3074-3081 (2006).
13. Tan, H.O. et al. Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy. Proc. Natl. Acad. Sci. USA 104, 17536-17541 (2007).
14. Hosford, D.A., Wang, Y. & Cao, Z. Differential effects mediated by GABAA receptors in thalamic nuclei in lh/lh model of absence seizures. Epilepsy Res. 27, 55-65 (1997).
15. Hosford, D.A. & Wang, Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin and topiramate against human absence seizures. Epilepsia 38, 408-414 (1997).
16. Danober, L., Deransart, C., Depaulis, A., Vergnes, M. & Marescaux, C. Pathophysiological mechanisms of genetic absence epilepsy in the rat. Prog. Neurobiol. 55, 27-57 (1998).
17. Perucca, E., Gram, L., Avanzini, G. & Dulac, O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 39, 5-17 (1998).
18. Ettinger, A.B. et al. Two cases of nonconvulsive status epilepticus in association with tiagabine therapy. Epilepsia 40, 1159-1162 (1999).
19. Farrant, M. & Nusser, Z. Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors. Nat. Rev. Neurosci. 6, 215-229 (2005).
20. Glykys, J. & Mody, I. Activation of GABAA receptors: views from outside the synaptic cleft. Neuron 56, 763-770 (2007).
21. Belelli, D., Peden, D.R., Rosahl, T.W., Wafford, K.A. & Lambert, J.J. Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics. J. Neurosci. 25, 11513-11520 (2005).
22. Cope, D.W., Hughes, S.W. & Crunelli, V. GABAA receptor-mediated tonic inhibition in thalamic neurons. J. Neurosci. 25, 11553-11563 (2005).
23. Jia, F. et al. An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons. J. Neurophysiol. 94, 4491-4501 (2005).
24. Bright, D.P., Aller, M.I. & Brickley, S.G. Synaptic release generates a tonic GABAA receptor-mediated conductance that modulates burst precision in thalamic relay neurons. J. Neurosci. 27, 2560-2569 (2007).
25. Laurie, D.J., Wisden, W. & Seeburg, P.H. The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J. Neurosci. 12, 4151-4172 (1992).
26. Fletcher, C.F. & Frankel, W.N. Ataxic mouse mutants and molecular mechanisms of absence epilepsy. Hum. Mol. Genet. 8, 1907-1912 (1999).
27. Snead, O.C., III. The γ-hydroxybutyrate model of absence seizures: correlation of regional brain levels of γ-hydroxybutyric acid and γ-butyrolactone with spike wave discharges. Neuropharmacology 30, 161-167 (1991).
28. Banerjee, P.K., Hirsch, E. & Snead, O.C., III. y-hydroxybutyric acid induced spike and wave discharges in rats: relation to high-affnity [3H]y-hydroxybutyric acid binding sites in the thalamus and cortex. Neuroscience 56, 11-21 (1993).
29. Fariello, R.G. & Golden, G.T. The THIP-induced model of bilateral synchronous spike and wave in rodents. Neuropharmacology 26, 161-165 (1987).
30. Le Feuvre, Y., Fricker, D. & Leresche, N. GABAA receptor-mediated IPSCs in rat thalamic sensory nuclei: patterns of discharge and tonic modulation by GABAB autoreceptors. J. Physiol. (Lond.) 502, 91-104 (1997).
31. Richards, D.A., Lemos, T., Whitton, P.S. & Bowery, N.G. Extracellular GABA in the ventrolateral thalamus of rats exhibiting spontaneous absence epilepsy: a microdialysis study. J. Neurochem. 65, 1674-1680 (1995).
32. Sutch, R.J., Davies, C.C. & Bowery, N.G. GABA release and uptake measured in crude synaptosomes from Genetic Absence Epilepsy Rats from Strasbourg (GAERS). Neurochem. Int. 34, 415-425 (1999).
33. Borden, L.A. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochem. Int. 29, 335-356 (1996).
34. De Biasi, S., Vitellaro-Zuccarello, L. & Brecha, N.C. Immunoreactivity for the GABA transporter-1 and GABA transporter-3 is restricted to astrocytes in the rat thalamus. A light and electron-microscopic immunolocalization. Neuroscience 83, 815-828 (1998).
35. Pow, D.V. et al. Differential expression of the GABA transporters GAT-1 and GAT-3 in brains of rats, cats, monkeys and humans. Cell Tissue Res. 320, 379-392 (2005).
36. Wu, Y., Wang, W., Díez-Sampdero, A. & Richerson, G.B. Nonvesicular inhibitory neurotransmission via reversal of the GABA transporter GAT-1. Neuron 56, 851-865 (2007).
37. Chiu, C.-S. et al. GABA transporter defciency causes tremor, ataxia, nervousness and increased GABA-induced tonic conductance in cerebellum. J. Neurosci. 25, 3234-3245 (2005).
38. Bragina, L. et al. GAT-1 regulates both tonic and phasic GABAA receptor-mediated inhibition in the cerebral cortex. J. Neurochem. 105, 1781-1793 (2008).
39. Herd, M.B. et al. Inhibition of thalamic excitability by 4,5,6,7-tetrahydroisoxazolo [4,5-c]pyridine-3-ol: a selective role for 5-GABAA receptors. Eur. J. Neurosci. 29, 1177-1187 (2009).
40. Aizawa, M., Ito, Y. & Fukuda, H. Pharmacological profles of generalized absence seizures in lethargic, stargazer and y-hydroxybutyrate- treated model mice. Neurosci. Res. 29, 17-25 (1997).
41. Maguire, J.L., Stell, B.M., Rafzadeh, M. & Mody, I. Ovarian cycle-linked changes in GABAA receptors mediating tonic inhibition alter seizures susceptibility and anxiety. Nat. Neurosci. 8, 797-804 (2005).
42. Stórustovu, S.I. & Ebert, B. Pharmacological characterization of agonists at 5-containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on the absence of y2. J. Pharmacol. Exp. Ther. 316, 1351-1359 (2006).
43. Quick, M.W., Corey, J.L., Davidson, N. & Lester, H.A. Second messengers, traffcking-related proteins and amino acid residues that contribute to the functional regulation of the rat brain GABA transporter GAT1. J. Neurosci. 17, 2967-2979 (1997).
44. Beckman, M.L., Bernstein, E.M. & Quick, M.W. Multiple G protein-coupled receptors initiate protein kinase C redistribution of GABA transporters in hippocampal neurons. J. Neurosci. 19, RC9 (1999).
45. Wang, D., Deken, S.L., Whitworth, T.L. & Quick, M.W. Syntaxin 1A inhibits GABA fux, effux and exchange mediated by the rat brain GABA transporter GAT1. Mol. Pharmacol. 64, 905-913 (2003).
46. Hu, J. & Quick, M.W. Substrate-mediated regulation of y-aminobutyric acid transporter 1 in rat brain. Neuropharmacology 54, 309-318 (2008).
47. Paxinos, G. & Watson, C. The Rat Brain in Stereotaxic Coordinates 2nd edn. (Academic Press, San Diego, 1986
48. Juhász, G., Kékesi, K., Emri, Z., Soltesz, I. & Crunelli, V. Sleep-promoting action of excitatory amino acid antagonists: a different role for thalamic NMDA and non-NMDA receptors. Neurosci. Lett. 114, 333-338 (1990)